Mental Disorders and Cardiovascular Diseases

Česká verzia

Authors: N. Hudáková ¹; P. Kala ²; M. Šebo ³; L. Ustohal ⁴; T. Kašpárek ⁴; J. Kaňovský ²
Authors place of work: LF MU, Brno ¹; Interní kardiologická klinikaLF MU a FN Brno ²; Centrum kardiovaskulární a transplantační chirurgie, Brno ³; Psychiatrická klinika LF MU a FN Brno ⁴
Published in the journal: Cesk Slov Neurol N 2016; 79/112(1): 25-30
Category: Review Article

Summary

Researchers currently focus on a wide range of aspects associated with coincidence of cardiovascular diseases and depression. These include a search for a possible causal link between depression and coexisting cardiovascular disorder as well as the association between depression and poorer recovery after myocardial infarction or higher complication rate. Major depression is connected with comorbidities such as the metabolic syndrome and diabetes mellitus. Impaired autonomous nerve system function and unhealthy lifestyle can also play their role. Depression is more frequent in patients with a history of myocardial infarction and is considered a major risk factor of poorer prognosis. It is undoubtedly important to screen this patient group for both depression and anxiety so that appropriate treatment can be initiated if needed.

Key words:
myocardial infarction – major depression – coronary artery disease

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Zdroje

1. Rosenman RH. The role of Type A behaviour pattern in ischaemic heart disease: modification of its effects by beta-blocking agents. Br J Clin Pract 1978; 32(1): 58– 65.

2. Weiss SM. Coronary-prone behavior and coronary heart disease – a critical review. Circulation 1981; 63(6): 1199– 1215.

3. Shekelle RB, Gale M, Ostfeld AM, Paul O. Hostility, risk of coronary heart disease and mortality. Psychosom Med 1983; 45(2): 109– 114.

4. Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings: blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. J Am Med Assoc 1959; 169(12): 1286– 1296.

5. Barefoot JC, Dahlstrom WG, Williams RB jr. Hostility, CHD incidence and total mortality: a 25-year follow-up study of 255 physicians. Psychosom Med 1983; 45(1): 59– 63.

6. Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 2009; 53(11): 936– 946. doi: 10.1016/ j.jacc.2008.11.044.

7. Smith TW. Hostility and health: current status of a psychosomatic hypothesis. Health Psychol 1992; 11(3): 139– 150.

8. Carroll D, Davey Smith G, Sheffield D, Shipley MJ, Marmot MG. The relationship between socioeconomic status, hostility, and blood pressure reactions to mental stress in men: data from the Whitehall II study. Health Psychol 1997; 16(2): 131– 136.

9. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347(8999): 417– 421.

10. Denollet J, Pedersen Ss, Vrints CJ, Conraads VM. Usefulness of type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease. Am J Cardiol 2006; 97(7): 970– 973.

11. Kubzansky LD, Davidson KW, Rozanski A. The clinical impact of negative psychological states: expanding the spectrum of risk for coronary artery disease. Psychosom Med 2005; 67 (Suppl 1): S10– S14.

12. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21(1): 30– 38.

13. Smolík P. Duševní a behaviorální poruchy. Praha: Max-dorf Jessenius 1996.

14. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol 2002; 7(1): 11.

15. Havik OE, Maeland JG. Patterns of emotional reactions after a myocardial infarction. J Psychosom Res 1990; 34(3): 271– 285.

16. Thompson DR, Webster RA, Cordle CJ, Sutton TW. Specific sources and patterns of anxiety in male patients with first myocardial infarction. Br J Med Psychol 1987; 60(4): 343– 348.

17. Damen NL, Pelle AJ, van Geuns R, van Domburg RT, Boersma E, Pedersen SS. Intra-individual changes in anxiety and depression during 12-month follow-up in percutaneous coronary intervention patients. J Affect Disord 2011; 134(1– 3): 464– 467. doi: 10.1016/ j.jad.2011.05.026.

18. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA J Am Med Assoc 1993; 270(15): 1819– 1825.

19. Frasure-Smith N, Lespérance F, Gravel G, Masson A, Juneau M, Talajic M et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 2000; 101(16): 1919– 1924.

20. Denollet J, Martens EJ, Smith OR, Burg MM. Efficient assessment of depressive symptoms and their prognostic value in myocardial infarction patients. J Affect Disord 2010; 120(1– 3): 105– 111. doi: 10.1016/ j.jad.2009.04.013.

21. Pedersen SS, Denollet J, Daemen J, van de Sande M, de Jaegere PT, Serruys PW et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res 2007; 62(4): 455– 461.

22. Strik JJ, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003; 42(10): 1801– 1807.

23. Grace SL, Abbey SE, Kapral MK, Fang J, Nolan RP, Stewart DE. Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol 2005; 96(9): 1179– 1185.

24. Damen NL, Versteeg H, Boersma E, Serruys PW, van Geuns RJ, Denollet J et al. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry. Int J Cardiol 2013; 167(6): 2496– 2501. doi: 10.1016/ j.ijcard.2012.04.028.

25. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289(23): 3106– 3116.

26. Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004; 66(4): 466– 474.

27. Glassman AH, O‘Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT jr et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288(6): 701– 709.

28. Glassman AH, Bigger JT jr, Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009; 66(9): 1022– 1029. doi: 10.1001/ archgenpsychiatry.2009.121.

29. De Jonge P, Honig A, van Melle JP, Schene AH, Kuyper AM, Tulner D et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007; 164(9): 1371– 1378.

30. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT et al. Platelet/ endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003; 108(8): 939– 944.

31. Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297(4): 367– 379.

32. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62(7): 792– 798.

33. Silverstone PH. Depression and outcome in acute myocardial infarction. Br Med J 1987; 294(6566): 219– 220.

34. Ladwig KH, Kieser M, König J, Breithardt G, Borggrefe M. Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J 1991; 12(9): 959– 964.

35. Frasure-Smith N, Lespérance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 1999; 61(1): 26– 37.

36. Welin C, Lappas G, Wilhelmsen L. Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 2000; 247(6): 629– 639.

37. Carney RM, Blumenthal, JA, Catellier D, Freedland KE, Berkman LF, Watkins Ll et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 2003; 92(11): 1277– 1281.

38. Carinci F, Nicolucci A, Ciampi A, Labbrozzi D, Bettinardi O, Zotti AM et al. Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction. Application of recursive partitioning techniques to the GISsI-2 database. Eur Heart J 1997; 18(5): 835– 845.

39. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction? QJM 2000; 93(11): 739– 744.

40. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62(2): 212– 219.

41. Shiotani I, Sato H, Kinjo K, Nakatani D, Mizuno H, Ohnishi Y et al. Depressive symptoms predict 12-month prognosis in elderly patients with acute myocardial infarction. J Cardiovasc Risk 2002; 9(3): 153– 160.

42. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66(6): 802– 813.

43. Van Melle JP, De Jonge P, Spijkerman TA, Tijssen JG, Ormel J, Van Veldhuisen DJ et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66(6): 814– 822.

44. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33(3): 203– 216. doi: 10.1016/ j.genhosppsych.2011.02.007.

45. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6,362 events among 146,538 participants in 54 observational studies. Eur Heart J 2006; 27(23): 2763– 2774.

46. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63(2): 221– 230.

47. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res 2001; 51(3): 497– 501.

48. Mayou R, Foster A, Williamson B. Psychosocial adjustment in patients one year after myocardial infarction. J Psychosom Res 1978; 22(5): 447– 453.

49. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160(12): 1818– 1823.

50. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003; 290(2): 215– 221.

51. Vreeburg SA, Hoogendijk WJ, van Pelt J, DeRijk RH, Verhagen JC, van Dyck R et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009; 66(6): 617– 626. doi: 10.1001/ archgenpsychiatry.2009.50.

52. Nečas E. Patologická fyziologie orgánových systémů – část I. Praha: Karolinum 2009.

53. Musselman DL, Tomer A, Manatunga AK, Knight BT. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153(10): 1313– 1317.

54. Wulsin LR, Musselman D, Otte C, Bruce E, Ali S, Whooley MA. Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study. Psychosom Med 2009; 71(3): 260– 265. doi: 10.1097/ PSY.0b013e31819cc761.

55. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001; 88(2): 196– 198.

56. Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005; 67 (Suppl 1): S29– S33.

57. Blumenthal JA, Sherwood A, Babyak MA, Watkins Ll, Waugh R, Georgiades A et al. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA 2005; 293(13): 1626– 1634.

58. Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression and the metabolic syndrome. Biol Psychiatry 2007; 62(11): 1251– 1257.

59. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Roux AV et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299(23): 2751– 2759. doi: 10.1001/ jama.299.23.2751.